- November 2, 2021
9:00 AM - 12:00 PM ET
The Food and Drug Administration (FDA or Agency) is announcing a virtual public meeting to discuss proposed recommendations for the reauthorization of the Biosimilar User Fee Act (BsUFA) for fiscal years (FYs) 2023 through 2027. The virtual public meeting will be held on November 2, 2021, from 9 a.m. to 12 p.m. (ET). The meeting agenda, public docket information, additional materials, and any other updates will also be posted to this website as they become available.
You can register for the meeting here to let FDA know that you plan to attend. Though registration is voluntary and not required to attend, registrants will receive email updates and notices when new information becomes available.
Date: November 2, 2021
Time: 9:00 AM - 12:00 PM ET
Webinar Meeting ID:
161 047 8285
Webinar Password (Case-Sensitive):
Register for this Event
[DEADLINE EXTENDED!] If you wish to make a verbal comment during the open public comment portion of the meeting, please submit the request form (also available on the Eventbrite page) by 11:59pm (ET) on October 26th.
|BsUFA III Public Meeting Agenda 11.02.2021||pdf (133.14 KB)|